U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07464717) titled 'Standard Versus Mini Percutaneous Nephrolithotomy for Renal Stones' on Jan. 13.
Brief Summary: Renal stone disease is a common urological condition associated with significant morbidity. Percutaneous nephrolithotomy (PCNL) is the standard treatment for renal stones larger than 2 cm. Although standard PCNL (Percutaneous nephrolithotomy) is associated with high stone-free rates, it carries a risk of complications such as bleeding and prolonged hospital stay. Mini percutaneous nephrolithotomy has been introduced as a less invasive alternative with the potential to reduce morbidity. However, evidence comparing outcomes between mini-PCN...